HemaSphere
(Jun 2022)
P724: THE BONE MARROW MESENCHYMAL CELL-DERIVED EXTRACELLULAR MATRIX IS SIGNIFICANTLY ALTERED IN PATIENTS WITH MELODYSPLASTIC SYNDROMES
- A. Bains,
- L. Behrens Wu,
- M. Richter,
- V. Magno,
- S. Rother,
- M. Cross,
- C. Werner,
- M. Wobus,
- U. Platzbecker
Affiliations
- A. Bains
- 1 Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig
- L. Behrens Wu
- 2 Department of Medicine I, University Hospital Carl Gustav Carus
- M. Richter
- 1 Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig
- V. Magno
- 3 Leibniz Institute of Polymer Research, Technische Universität, Dresden, Dresden
- S. Rother
- 4 Center for Molecular Signaling, Saarland University School of Medicine, Homburg (Saar), Germany
- M. Cross
- 1 Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig
- C. Werner
- 3 Leibniz Institute of Polymer Research, Technische Universität, Dresden, Dresden
- M. Wobus
- 2 Department of Medicine I, University Hospital Carl Gustav Carus
- U. Platzbecker
- 1 Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig
- DOI
-
https://doi.org/10.1097/01.HS9.0000845780.08087.f1
- Journal volume & issue
-
Vol. 6
pp.
619
– 620
WeChat QR code